Masimo Corp. Company Profile (NASDAQ:MASI)

About Masimo Corp.

Masimo Corp. logoMasimo Corporation is a medical technology company that develops, manufactures and markets non-invasive patient monitoring products. The Company's business is measure-through-motion and low-perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry. Its product offerings include monitoring blood constituents with an optical signature, optical organ oximetry monitoring, electrical brain function monitoring, acoustic respiration monitoring and exhaled gas monitoring. The Company has developed the Root patient monitoring and connectivity platform, the Radical-7 bedside and portable patient monitor and the Radius-7 wearable wireless patient monitor. It has also developed the Patient SafetyNet remote patient surveillance monitoring system, which allows over 200 patients to be monitored simultaneously and remotely through a personal computer (PC)-based viewing station or by care providers through their voice-over-Internet Protocol (IP) phones.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: Health Care Equipment
  • Exchange: NASDAQ
  • Symbol: MASI
  • CUSIP: 57479510
Key Metrics:
  • Previous Close: $56.47
  • 50 Day Moving Average: $59.17
  • 200 Day Moving Average: $53.09
  • 52-Week Range: $33.03 - $60.81
  • Trailing P/E Ratio: 29.61
  • Foreward P/E Ratio: 25.90
  • P/E Growth: 1.96
  • Market Cap: $2.79B
  • Outstanding Shares: 49,351,000
  • Beta: 0.7
  • Net Margins: 15.40%
  • Return on Equity: 29.07%
  • Return on Assets: 13.39%
  • Debt-to-Equity Ratio: 0.59%
  • Current Ratio: 2.46%
  • Quick Ratio: 1.94%
Additional Links:
Companies Related to Masimo Corp.:

Analyst Ratings

Consensus Ratings for Masimo Corp. (NASDAQ:MASI) (?)
Ratings Breakdown: 1 Hold Rating, 4 Buy Ratings
Consensus Rating:Buy (Score: 2.80)
Consensus Price Target: $53.00 (6.14% downside)

Analysts' Ratings History for Masimo Corp. (NASDAQ:MASI)
DateFirmActionRatingPrice TargetDetails
8/5/2016Piper Jaffray Cos.Reiterated RatingOverweight$52.00 -> $55.00View Rating Details
8/5/2016BTIG ResearchReiterated RatingHoldView Rating Details
8/4/2016WedbushReiterated RatingOutperform$60.00 -> $63.00View Rating Details
6/1/2016Raymond James Financial Inc.DowngradeStrong-Buy -> OutperformView Rating Details
5/5/2016Roth CapitalBoost Price TargetBuy$40.00 -> $50.00View Rating Details
1/9/2015Off Wall StreetReiterated RatingSellView Rating Details
(Data available from 10/27/2014 forward)


Earnings History for Masimo Corp. (NASDAQ:MASI)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/2/2016Q316$0.42$165.51 millionListenView Earnings Details
8/3/2016Q216$0.41$0.57$166.02 million$172.64 millionViewListenView Earnings Details
5/4/2016Q116$0.43$0.53$165.25 million$171.20 millionViewListenView Earnings Details
2/23/2016Q415$0.39$0.15$164.25 million$167.30 millionViewListenView Earnings Details
11/5/2015Q315$0.31$0.36$149.31 million$152.60 millionViewListenView Earnings Details
8/4/2015Q215$0.32$0.36$147.93 million$155.73 millionViewListenView Earnings Details
5/6/2015Q115$0.35$0.41$151.00 million$154.54 millionViewListenView Earnings Details
2/17/2015Q414$0.37$0.40$159.45 million$161.80 millionViewListenView Earnings Details
10/29/2014Q314$0.25$0.27$144.20 million$144.10 millionViewListenView Earnings Details
8/7/2014Q214$0.29$0.24$145.76 million$140.92 millionViewListenView Earnings Details
4/30/2014Q114$0.29$0.30$144.01 million$139.80 millionViewListenView Earnings Details
2/13/2014Q413$0.31$0.31$148.25 million$134.70 millionViewListenView Earnings Details
10/30/2013Q313$0.26$0.27$132.47 million$131.40 millionViewListenView Earnings Details
7/31/2013Q2 2013$0.28$0.30$136.36 million$137.42 millionViewListenView Earnings Details
5/2/2013Q1 2013$0.28$0.28$134.46 million$135.90 millionViewListenView Earnings Details
2/14/2013Q4 2012$0.29$0.26$129.09 million$132.20 millionViewListenView Earnings Details
11/1/2012Q312$0.26$0.26$120.99 million$112.10 millionViewN/AView Earnings Details
8/1/2012$0.28$0.27ViewN/AView Earnings Details
5/2/2012$0.28$0.27ViewN/AView Earnings Details
2/14/2012$0.23$0.23ViewN/AView Earnings Details
10/25/2011$0.27$0.24ViewN/AView Earnings Details
8/9/2011$0.28$0.28ViewN/AView Earnings Details
5/3/2011$0.30$0.30ViewN/AView Earnings Details
2/15/2011$0.26$0.29ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Masimo Corp. (NASDAQ:MASI)
Current Year EPS Consensus Estimate: $2.02 EPS
Next Year EPS Consensus Estimate: $2.18 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20165$0.40$0.43$0.42
Q2 20164$0.41$0.42$0.41
Q3 20164$0.41$0.43$0.42
Q4 20164$0.49$0.53$0.51
Q1 20171$0.54$0.54$0.54
Q2 20171$0.53$0.53$0.53
Q3 20171$0.50$0.50$0.50
Q4 20171$0.57$0.57$0.57
(Data provided by Zacks Investment Research)


Dividend History for Masimo Corp. (NASDAQ:MASI)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Masimo Corp. (NASDAQ:MASI)
Insider Ownership Percentage: 16.60%
Institutional Ownership Percentage: 79.86%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/19/2016Sanford FitchDirectorSell2,000$59.05$118,100.00View SEC Filing  
10/10/2016Joe E KianiCEOSell84,617$60.26$5,099,020.42View SEC Filing  
10/10/2016Yongsam LeeEVPSell30,000$60.50$1,815,000.00View SEC Filing  
10/5/2016Sanford FitchDirectorSell2,000$59.58$119,160.00View SEC Filing  
10/4/2016Joe E KianiCEOSell4,300$60.07$258,301.00View SEC Filing  
10/3/2016Joe E KianiCEOSell2,200$60.00$132,000.00View SEC Filing  
9/30/2016Thomas Samuel McclenahanEVPSell10,000$59.00$590,000.00View SEC Filing  
9/27/2016Joe E KianiCEOSell4,464$60.01$267,884.64View SEC Filing  
9/22/2016Joe E KianiCEOSell49,484$60.18$2,977,947.12View SEC Filing  
9/21/2016Sanford FitchDirectorSell2,000$59.41$118,820.00View SEC Filing  
9/20/2016Joe E KianiCEOSell400$60.16$24,064.00View SEC Filing  
9/19/2016Joe E KianiCEOSell999$60.03$59,969.97View SEC Filing  
9/7/2016Joe E KianiCEOSell33,536$60.00$2,012,160.00View SEC Filing  
9/7/2016Jon ColemanInsiderSell6,000$60.00$360,000.00View SEC Filing  
9/7/2016Sanford FitchDirectorSell2,000$59.81$119,620.00View SEC Filing  
8/17/2016Sanford FitchDirectorSell2,000$58.11$116,220.00View SEC Filing  
8/4/2016Jon ColemanInsiderSell22,000$56.82$1,250,040.00View SEC Filing  
8/4/2016Paul JansenEVPSell10,000$58.88$588,800.00View SEC Filing  
8/3/2016Sanford FitchDirectorSell2,000$52.62$105,240.00View SEC Filing  
7/20/2016Rick FishelInsiderSell22,000$53.85$1,184,700.00View SEC Filing  
7/20/2016Sanford FitchDirectorSell3,000$53.48$160,440.00View SEC Filing  
6/30/2016Ramshorst David J VanCAOSell5,000$52.50$262,500.00View SEC Filing  
6/7/2016Joe E KianiCEOSell65,048$50.00$3,252,400.00View SEC Filing  
6/3/2016Joe E KianiCEOSell234,952$50.09$11,768,745.68View SEC Filing  
6/1/2016Jon ColemanInsiderSell4,000$50.00$200,000.00View SEC Filing  
5/31/2016Raad Mark DeCFOSell40,000$49.43$1,977,200.00View SEC Filing  
5/25/2016Rick FishelInsiderSell25,000$49.85$1,246,250.00View SEC Filing  
5/5/2016Jon ColemanInsiderSell8,000$47.00$376,000.00View SEC Filing  
4/28/2016Paul JansenEVPSell10,000$44.88$448,800.00View SEC Filing  
4/27/2016Jon ColemanInsiderSell4,000$44.00$176,000.00View SEC Filing  
3/23/2016Yongsam LeeEVPSell96,000$39.96$3,836,160.00View SEC Filing  
3/22/2016Yongsam LeeEVPSell32,000$40.06$1,281,920.00View SEC Filing  
3/21/2016Yongsam LeeEVPSell32,000$39.83$1,274,560.00View SEC Filing  
3/15/2016Raad Mark DeCFOSell40,000$39.00$1,560,000.00View SEC Filing  
2/29/2016Raad Mark DeCFOSell40,000$38.11$1,524,400.00View SEC Filing  
12/24/2015Jon ColemaninsiderSell10,000$42.00$420,000.00View SEC Filing  
12/9/2015Sanford FitchDirectorSell2,000$41.00$82,000.00View SEC Filing  
11/11/2015Sanford FitchDirectorSell2,000$42.67$85,340.00View SEC Filing  
11/6/2015Anand SampathCOOSell45,000$42.00$1,890,000.00View SEC Filing  
11/6/2015Jon ColemaninsiderSell10,000$42.38$423,800.00View SEC Filing  
10/14/2015Sanford FitchDirectorSell2,000$39.29$78,580.00View SEC Filing  
9/17/2015Paul JansenEVPSell10,000$42.88$428,800.00View SEC Filing  
9/9/2015Sanford FitchDirectorSell2,000$41.29$82,580.00View SEC Filing  
8/31/2015Thomas Samuel McclenahanEVPSell22,000$40.62$893,640.00View SEC Filing  
8/26/2015Paul JansenEVPSell10,000$40.88$408,800.00View SEC Filing  
7/22/2015Rick FishelInsiderSell35,084$41.85$1,468,265.40View SEC Filing  
7/21/2015Joe E KianiCEOSell300,000$40.55$12,165,000.00View SEC Filing  
7/21/2015Steven BarkerDirectorSell20,000$40.00$800,000.00View SEC Filing  
7/8/2015Sanford FitchDirectorSell2,000$38.18$76,360.00View SEC Filing  
6/10/2015Sanford FitchDirectorSell2,000$36.49$72,980.00View SEC Filing  
6/4/2015Steven BarkerDirectorSell25,000$36.20$905,000.00View SEC Filing  
4/8/2015Sanford FitchDirectorSell2,000$34.57$69,140.00View SEC Filing  
2/18/2015Rick FishelInsiderSell18,170$29.85$542,374.50View SEC Filing  
5/22/2013Robert ColemanDirectorSell59,400$21.93$1,302,642.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Masimo Corp. (NASDAQ:MASI)
DateHeadline logoEPS Target Of Masimo Corporation (NASDAQ:MASI) At $0.42 ... - Stocks Daily (NASDAQ:MASI) - October 26 at 6:04 PM logoMasimo Up 49.9% Since SmarTrend Uptrend Call (MASI) (NASDAQ:MASI) - October 26 at 9:26 AM logoMasimo : Assigned Patent (NASDAQ:MASI) - October 26 at 9:26 AM logoMasimo Corp. breached its 50 day moving average in a Bearish Manner : MASI-US : October 24, 2016 (NASDAQ:MASI) - October 24 at 11:27 AM logo11:29 am Masimo presented study that investigates the impact of Masimo continuous SpHb and PVI on anesthesia-related mortality (NASDAQ:MASI) - October 23 at 5:51 PM logoStudy Investigates the Impact of Masimo Continuous SpHb® and PVI® on Anesthesia-Related Mortality (NASDAQ:MASI) - October 23 at 10:21 AM
News IconInsider Deal: Sanford Fitch Unloaded 2,000 Shares of Masimo Corporation (NASDAQ:MASI) (NASDAQ:MASI) - October 22 at 5:40 PM
News IconInsider Deal: Sanford Fitch Unloaded 2000 Shares of Masimo Corporation (NASDAQ:MASI) - Thorold News (NASDAQ:MASI) - October 22 at 10:09 AM logoETF’s with exposure to Masimo Corp. : October 19, 2016 (NASDAQ:MASI) - October 19 at 6:24 PM logoMasimo : to Report Third Quarter 2016 Financial Results after Market Close on Wednesday, November 2 (NASDAQ:MASI) - October 19 at 10:58 AM logoMasimo to Report Third Quarter 2016 Financial Results after Market Close on Wednesday, November 2 (NASDAQ:MASI) - October 19 at 10:58 AM logoMasimo Corporation (NASDAQ:MASI) EPS Forecast At $0.42 (NASDAQ:MASI) - October 16 at 10:30 AM
News IconUpdate on Masimo Corporation (NASDAQ:MASI) for the day (NASDAQ:MASI) - October 15 at 10:48 AM
News IconPulse Oximetry Sales Market Report 2016: Masimo Corp, CAS Medical Systems, Zensorium, Covidien PLC, Medtronic, Opto Circuits (NASDAQ:MASI) - October 14 at 9:20 AM
News IconAnalysts Take the Wheel on Masimo Corporation (NASDAQ:MASI) Shares and Where They Might Be Headed - CSZ News (NASDAQ:MASI) - October 13 at 9:37 AM logoMasimo Corp. breached its 50 day moving average in a Bullish Manner : MASI-US : October 13, 2016 (NASDAQ:MASI) - October 13 at 9:37 AM
News IconInsider Sale: Masimo Corporation (NASDAQ:MASI)’s EVP & CIO Yongsam Lee Sold 30,000 shares (NASDAQ:MASI) - October 12 at 11:17 AM logoMasimo Corp (MASI) CEO and Chairman of the Board Joe E Kiani Sold $5.1 million of Shares (NASDAQ:MASI) - October 12 at 11:17 AM logoMasimo Corporation (NASDAQ:MASI) Deferred Tax Assets At $19.636 (NASDAQ:MASI) - October 10 at 5:43 PM logoMasimo Corporation (NASDAQ:MASI) Mean Rating At $1.83 (NASDAQ:MASI) - October 9 at 10:21 AM logoMasimo Corp. (MASI) Announces Receipt of CE Mark for Rad-97 ... - (NASDAQ:MASI) - October 6 at 5:53 PM logoMasimo Corp. (MASI) Announces Receipt of CE Mark for Rad-97 Pulse CO-Oximeter (NASDAQ:MASI) - October 6 at 11:31 AM logoMasimo Announces CE Marking of Rad-97™ Pulse CO-Oximeter® (NASDAQ:MASI) - October 6 at 11:31 AM
News IconMasimo Corporation (NASDAQ:MASI) Updated Broker Price Targets (NASDAQ:MASI) - October 4 at 4:08 PM logoJustices Reject Bias Dispute Over Arbitrator’s BigLaw Brother (NASDAQ:MASI) - October 3 at 5:42 PM logoMasimo Corporation (NASDAQ:MASI) Accounts Payable At $25.865 Millions (NASDAQ:MASI) - October 3 at 5:42 PM logoMASI Crosses Above Average Analyst Target (NASDAQ:MASI) - October 3 at 10:39 AM logoMasimo Honors Birthday of Mahatma Gandhi With Global Holiday (NASDAQ:MASI) - October 2 at 5:20 PM logoMasimo Corporation (NASDAQ:MASI): Price Target Stands At $59.2 - (NASDAQ:MASI) - October 1 at 5:25 PM logoAnalysts Set EPS Target of $0.42 For Masimo Corporation (NASDAQ:MASI) - Stocks Daily (NASDAQ:MASI) - October 1 at 5:25 PM logoAnalysts Set EPS Target of $0.42 For Masimo Corporation (NASDAQ:MASI) (NASDAQ:MASI) - October 1 at 11:24 AM logoMasimo Corporation (NASDAQ:MASI) Mean Price Target At $59.2 (NASDAQ:MASI) - September 30 at 6:13 PM logoMasimo Partners with Smile Train to Advance Safe Surgery (NASDAQ:MASI) - September 30 at 6:12 PM
News IconBroker Roundup For Masimo Corporation (NASDAQ:MASI) (NASDAQ:MASI) - September 29 at 11:05 AM logoABIOMED Raised to Strong Buy: Should You Add the Stock? (NASDAQ:MASI) - September 29 at 11:05 AM logoStereotaxis secures $24 million in equity financing (NASDAQ:MASI) - September 27 at 5:57 PM logoMasimo Foundation Co-Finds the United for Oxygen Alliance (NASDAQ:MASI) - September 26 at 10:42 AM logoMasimo Foundation Co-Founds United for Oxygen Alliance (NASDAQ:MASI) - September 25 at 5:25 PM logoUptrend Call Working As Masimo Stock Rises 53.3% (MASI) (NASDAQ:MASI) - September 23 at 5:41 PM logoMasimo (MASI) Hits 52-Week High on Solid Growth Prospects - Nasdaq (NASDAQ:MASI) - September 21 at 5:45 PM logoMEDNAX (MD) Concludes Buyout of Anesthesiology Practices (NASDAQ:MASI) - September 21 at 10:09 AM logoMasimo Corporation (NASDAQ:MASI)’s Accounts Payable Is $30.71 (NASDAQ:MASI) - September 20 at 11:10 AM logoMasimo (MASI) Hits 52-Week High on Solid Growth Prospects (NASDAQ:MASI) - September 20 at 11:10 AM logoMasimo Corporation (NASDAQ:MASI)'s Accounts Payable Is $30.71 - (NASDAQ:MASI) - September 19 at 6:00 PM logoResearch Analysts Set Masimo Corporation (NASDAQ:MASI)’s Price Target At $59.2 (NASDAQ:MASI) - September 18 at 10:25 AM logoMasimo Corp. (MASI) Announces Publication of Positive Masimo ... - (NASDAQ:MASI) - September 15 at 4:02 PM logoMasimo Corp. (MASI) Announces Publication of Positive Masimo PVI Data (NASDAQ:MASI) - September 15 at 9:27 AM logoStudy on Abdominal Surgical Patients Investigates Clinical Utility of Masimo PVI® (NASDAQ:MASI) - September 15 at 9:27 AM logoMasimo Corporation (NASDAQ:MASI) Is Expected To Post EPS Of $0.52 (NASDAQ:MASI) - September 14 at 10:18 AM logoMasimo (MASI) Presents Encouraging SpHb Study Data (NASDAQ:MASI) - September 12 at 10:42 AM


Masimo Corp. (NASDAQ:MASI) Chart for Thursday, October, 27, 2016

Last Updated on 10/27/2016 by Staff